ELETRIPTAN ZENTIVA 40 mg, film-coated tablet 10 tablets
Active ingredients: Eletriptan hydrobromide monohydrate, ÉLÉTRIPTAN
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet10 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ELETRIPTAN ZENTIVA 40 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- plaquette(s) PVC polychlortrifluoroéthylène aluminium de 10 comprimé(s)
- Marketing authorisation holder
- ZENTIVA FRANCE
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 17 May 2019
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
62080918CIP73009498CIP133400930094983Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| BROMHYDRATE D'ÉLÉTRIPTAN MONOHYDRATÉcomprimé | 50,34 mg · un comprimé | SA |
| ÉLÉTRIPTANcomprimé | 40 mg · un comprimé | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.